News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
659,228 Results
Type
Article (54029)
Company Profile (197)
Press Release (604993)
Multimedia
Podcasts (123)
Webinars (15)
Section
Business (179911)
Career Advice (2738)
Deals (33199)
Drug Delivery (130)
Drug Development (79359)
Employer Resources (167)
FDA (16749)
Job Trends (15307)
News (318047)
Policy (32562)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2856)
Accelerated approval (34)
Adcomms (35)
Allergies (146)
Alliances (46557)
ALS (173)
Alzheimer's disease (1719)
Antibody-drug conjugate (ADC) (331)
Approvals (16937)
Artificial intelligence (536)
Autoimmune disease (161)
Automation (38)
Bankruptcy (342)
Best Places to Work (11574)
BIOSECURE Act (19)
Biosimilars (203)
Biotechnology (133)
Bladder cancer (162)
Brain cancer (64)
Breast cancer (657)
Cancer (4882)
Cardiovascular disease (439)
Career advice (2328)
Career pathing (40)
CAR-T (296)
CDC (56)
Celiac Disease (2)
Cell therapy (779)
Cervical cancer (34)
Clinical research (68035)
Collaboration (1766)
Company closure (5)
Compensation (536)
Complete response letters (72)
COVID-19 (2952)
CRISPR (94)
C-suite (842)
Cystic fibrosis (149)
Data (6170)
Decentralized trials (2)
Denatured (27)
Depression (145)
Diabetes (520)
Diagnostics (6730)
Digital health (42)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (250)
Drug pricing (211)
Drug shortages (32)
Duchenne muscular dystrophy (236)
Earnings (70277)
Editorial (64)
Employer branding (22)
Employer resources (151)
Events (90049)
Executive appointments (991)
FDA (19878)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1488)
Gene editing (206)
Generative AI (48)
Gene therapy (636)
GLP-1 (1095)
Government (5017)
Grass and pollen (8)
Guidances (384)
Healthcare (18790)
HIV (62)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (276)
Immuno-oncology (57)
Indications (100)
Infectious disease (3232)
Inflammatory bowel disease (190)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (243)
Interviews (513)
IPO (14838)
IRA (51)
Job creations (4044)
Job search strategy (1916)
JPM (68)
Kidney cancer (16)
Labor market (77)
Layoffs (632)
Leadership (39)
Legal (7391)
Liver cancer (98)
Longevity (15)
Lung cancer (663)
Lymphoma (375)
Machine learning (42)
Management (60)
Manufacturing (797)
MASH (166)
Medical device (13649)
Medtech (13697)
Mergers & acquisitions (19342)
Metabolic disorders (1358)
Multiple sclerosis (162)
NASH (21)
Neurodegenerative disease (347)
Neuropsychiatric disorders (94)
Neuroscience (2997)
Neurotech (1)
NextGen: Class of 2026 (6773)
Non-profit (4882)
Now hiring (55)
Obesity (660)
Opinion (303)
Ovarian cancer (164)
Pain (210)
Pancreatic cancer (223)
Parkinson's disease (294)
Partnered (33)
Patents (469)
Patient recruitment (482)
Peanut (59)
People (55957)
Pharmaceutical (32)
Pharmacy benefit managers (32)
Phase 1 (21173)
Phase 2 (29703)
Phase 3 (22738)
Pipeline (5125)
Policy (315)
Postmarket research (2564)
Preclinical (8260)
Press Release (63)
Prostate cancer (242)
Psychedelics (52)
Radiopharmaceuticals (264)
Rare diseases (884)
Real estate (5740)
Recruiting (73)
Regulatory (24690)
Reports (40)
Research institute (2575)
Resumes & cover letters (416)
Rett syndrome (28)
RNA editing (16)
RSV (83)
Schizophrenia (152)
Series A (250)
Series B (192)
Service/supplier (8)
Sickle cell disease (101)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (3606)
State (1)
Stomach cancer (19)
Supply chain (108)
Tariffs (96)
The Weekly (94)
Vaccines (1117)
Venture capital (96)
Weight loss (451)
Women's health (82)
Worklife (22)
Date
Last 7 days (545)
Last 30 days (1873)
Last 365 days (28365)
2026 (2739)
2025 (28771)
2024 (33081)
2023 (37836)
2022 (48493)
2021 (52902)
2020 (52608)
2019 (46511)
2018 (35735)
2017 (32328)
2016 (31338)
2015 (35415)
2014 (27071)
2013 (22252)
2012 (23986)
2011 (24759)
2010 (22068)
Location
Africa (946)
Alabama (85)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (39317)
Australia (6769)
California (10696)
Canada (2845)
China (1073)
Colorado (461)
Connecticut (442)
Delaware (280)
Europe (90557)
Florida (1493)
Georgia (325)
Hawaii (4)
Idaho (62)
Illinois (827)
India (64)
Indiana (501)
Iowa (21)
Japan (403)
Kansas (117)
Kentucky (41)
Louisiana (25)
Maine (80)
Maryland (1275)
Massachusetts (6897)
Michigan (310)
Minnesota (564)
Mississippi (6)
Missouri (131)
Montana (29)
Nebraska (28)
Nevada (118)
New Hampshire (84)
New Jersey (2694)
New Mexico (31)
New York (2716)
North Carolina (1338)
North Dakota (10)
Northern California (5120)
Ohio (301)
Oklahoma (21)
Oregon (41)
Pennsylvania (1981)
Puerto Rico (22)
Rhode Island (44)
South America (1293)
South Carolina (62)
South Dakota (1)
Southern California (4257)
Tennessee (168)
Texas (1572)
United States (36448)
Utah (347)
Vermont (1)
Virginia (253)
Washington D.C. (78)
Washington State (860)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
659,228 Results for "limflow sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Inari Medical Closes Acquisition of LimFlow
Inari Medical, Inc. announced the close of its acquisition of LimFlow S.A., a privately-held pioneer in limb salvage for patients with chronic limb-threatening ischemia.
November 15, 2023
·
3 min read
Deals
LimFlow Announces Agreement to Be Acquired by Inari Medical
LimFlow SA announced that it has entered into a definitive agreement to be acquired by Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.
November 1, 2023
·
3 min read
Press Releases
Battelle Named Key Subcontractor to SA-TECH for Mission Support Services Contract at U.S. Army Dugway Proving Ground
January 30, 2026
·
3 min read
Deals
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
Inari Medical, Inc. announced that it has entered into a definitive agreement to acquire LimFlow, S.A., a privately held pioneer in limb salvage for patients with chronic limb-threatening ischemia.
November 1, 2023
·
9 min read
FDA
FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options
LimFlow SA announced today that the U.S. Food and Drug Administration (FDA) has approved the LimFlow System to help people with CLTI who have no other suitable endovascular or surgical treatment options and are facing major amputation.
September 12, 2023
·
5 min read
Press Releases
POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar
November 24, 2025
·
19 min read
Press Releases
Moolec Science S.A. Receives Nasdaq Staff Memo Supporting Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders’ Equity Requirement
January 26, 2026
·
4 min read
Press Releases
Urteste S.A. launches European multicenter clinical study of the Panuri test
November 7, 2025
·
4 min read
Landmark New England Journal of Medicine Publication Reports Positive Results From PROMISE II Pivotal Trial Showing that LimFlow System Saves Most Patients with End-stage Peripheral Artery Disease From Major Amputation
LimFlow SA announced that results from the PROMISE II U.S. pivotal trial were published.
March 30, 2023
·
6 min read
Business
LimFlow Appoints Jenny Gaffney as Vice President, Health Economics and Reimbursement
LimFlow SA today announced the appointment of Jenny Gaffney as Vice President, Health Economics and Reimbursement.
August 23, 2022
·
3 min read
1 of 65,923
Next
